Fundraising FoxVirpax Pharmaceuticals
Berwyn, US · Founded 2017 · Delaware corporation
Find your way into Virpax Pharmaceuticals
Sign up to see every warm intro you have to Virpax Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Virpax Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Virpax Pharmaceuticals was founded in 2017 by Anthony Mack.
AM
Anthony MackFounder
GB
Gerald BruceExecutive
VS
Vinay ShahExecutive
SM
Sheila MathiasExecutiveSheila Mathias is an Executive Officer at Virpax Pharmaceuticals with regulatory and drug development experience spanning discovery through late-stage clinical trials across multiple therapeutic areas, having led submissions to the FDA and other health authorities throughout her pharmaceutical industry career.
TJ
Thani JambulingamNamed on SEC filing
JG
Jeffrey GudinNamed on SEC filing
JS
Jerrold SendrowNamed on SEC filing
Board
GH
Gary HermanBoard director
VM
Vanila M. SinghBoard director
KF
Katharyn FieldBoard director
JS
Judy SuBoard director
EF
Eric FloydBoard director
Reported raises · per SEC filings
Form D private placements$3.9M disclosed across 2 rounds · 2018–2024
▶$2.5MraisedJul 2024 · 1 investors · PharmaceuticalsRule 506(b)
▶$2.5MraisedJul 2024 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Vanila M. SinghDirector
- Gerald BruceExecutive Officer, Director
- Gary HermanDirector
- Vinay ShahExecutive Officer
- Katharyn FieldDirector
- Judy SuDirector
- Sheila MathiasExecutive Officer
- Eric FloydDirector
- Jatinder DhaliwalDirector
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.4MraisedApr 2018 · 8 investors · PharmaceuticalsRule 506(b)
▶$1.4MraisedApr 2018 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Thani JambulingamDirector
- Anthony MackExecutive Officer, Director
- Jeffrey GudinExecutive Officer, Director
- Eric FloydDirector
- Jerrold SendrowDirector
- Offering amount
- $3M
- Amount sold
- $1.4M
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Virpax Pharmaceuticals?
- Virpax Pharmaceuticals was founded by Anthony Mack in 2017.
- How much funding has Virpax Pharmaceuticals raised?
- Virpax Pharmaceuticals has disclosed $3.9M raised across 2 rounds.
- Where is Virpax Pharmaceuticals headquartered?
- Virpax Pharmaceuticals is headquartered in Berwyn, US.